Evidence map›Paper›PMID 32086250›Full record

ArticleBiology open2020

A new rat model of treatment-naive quiescent choroidal neovascularization induced by human VEGF165 overexpression.

Shan Liu, Antje K Biesemeier, Alexander V Tschulakow, Harsh V Thakkar, Sylvie Julien-Schraermeyer, Ulrich Schraermeyer

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Pigment Epithelium-Derived Factor (PEDF)-Based Therapy Induced Photoreceptor Survival by Stabilizing Choroidal Neovessels in a VEGF Overexpression CNV Rat Model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shan LiuCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany.
Antje K BiesemeierCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany.
Alexander V TschulakowCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany.
Harsh V ThakkarCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany.
Sylvie Julien-SchraermeyerCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany.
Ulrich SchraermeyerCenter for Ophthalmology, Division of Experimental Vitreoretinal Surgery, Tübingen 72076, Germany ulrich.schraermeyer@med.uni-tuebingen.de.ORCID 0000-0002-7969-8426
STZ eyetrial · DENatural and Medical Sciences Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular endothelial growth factor (VEGF) is a crucial stimulator for choroidal neovascularization (CNV). Our aim was to develop a reproducible and valid treatment-naive quiescent CNV (i.e. without signs of exudation and with normal visual acuity) rat model by subretinal injection of an adeno-associated virus (AAV)-VEGFA165 vector. The CNV development was longitudinally followed up

Indexed as

Gene ExpressionAnimalsAnimals, Genetically ModifiedChoroidal NeovascularizationDisease Models, AnimalDNA Copy Number VariationsFemaleFluorescein AngiographyHumansImmunohistochemistryRatsRetinal Pigment EpitheliumTomography, Optical CoherenceVascular Endothelial Growth Factor AVascular Endothelial Growth Factor AVEGFA protein, humanAge-related macular degeneration (AMD)AngiogenesisBevacizumabChoroidal neovascularization (CNV)Electron microscopy (EM)Vascular endothelial growth factor (VEGF)

Identifiers

PMID32086250
PMCPMC7295592
OpenAlexW3008136219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.